Estimates the 30-day mortality risk following acute pulmonary embolism.
Audience: PRACTITIONER
Published by OSU Center for Health Sciences
Revision 2 · Published May 19, 2025
The sPESI was designed to remove the complexity associated with the elements of the Pulmonary Embolism Severity Index (PESI) Risk Calculator in risk stratifying patients with Pulmonary Embolism (PE).
The sPESI has been:
Validation Studies: Jimenez 2010, Zhou 2012, Lankeit 2011.
It is important to note that:
The sPESI is meant to aid in clinical decision making, not as a replacement. Clinical judgement should always take precedence.
In the setting of renal failure or severe complicating comorbidities, clinical judgement should be used over the ePESI, as these patients were excluded in the validation studies.
Criteria
If any of the following criteria is/are present, the patient is considered to have a HIGH 30-day mortality risk (8.9% or greater).
| Age (years) | ≤ 80 (0 points) | > 80 (1 point) |
| Heart Rate (bpm) | < 110 (0 points) | ≥ 110 (1 point) |
| Oxygen Saturation | ≥ 90% (0 points) | < 90% (1 point) |
| Systolic Blood Pressure | ≥ 100(0 points) | < 100 (1 point) |
| History of Cancer | No (0 points) | Yes (1 point) |
| History of Chronic Cardiopulmonary Disease | No (0 points) | Yes (1 point) |
Results
Low-Mortality Risk: sPESI = 0
If no criteria are positive, the 30-day risk of mortality is 1.1%.
Patient may be a candidate for Outpatient PE management.
High Mortality Risk: sPESI ≥ 1
If any criteria are positive, the 30-day risk of mortality is 8.9% or higher.
Patient is a candidate for Inpatient PE management.
The Simplified PESI (sPESI) is used in the setting of acute pulmonary embolism (PE) to estimate a patient's 30-day mortality risk. This value helps determine if the patient is a candidate for outpatient PE management.
Patients with a LOW mortality risk (ePESI of 0) may be candidate for OUTPATIENT PE management (30-day mortality risk of 1.1%).
Patients with HIGH mortality risk (ePESI of 1 or greater) are recommended for INPATIENT PE management (30-day mortality risk of 8.9% or greater).
Current: Revision 2
About this evaluation